NCT00693771View on ClinicalTrials.gov

Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Glargine

Once daily and up-titrate accordingly

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Shanghai

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY